Evidence map›Paper›PMID 31139228›Full record

ArticleJournal of contemporary brachytherapy2019

Concurrent chemoradiotherapy for locally advanced squamous cell carcinoma of the cervix in a uterus didelphys with vaginal septum.

Yuko Kaneyasu, Iemasa Koh, Hisaya Fujiwara, Eiji Hirata, Yoshiki Kudo, Koji Arihiro, Norio Miharu, Tomio Nakagawa, Ippei Takahashi, Yuki Takeuchi and 6 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of contemporary brachytherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Uterus didelphys and cervical cancer: A case report.Gynecologic oncology reports · 2024
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Yuko KaneyasuDepartment of Radiation Oncology, National Hospital Organization Fukuyama Medical Center, Hiroshima, Japan.
Iemasa KohDepartment of Obstetrics and Gynecology, Hiroshima University, Hiroshima, Japan.
Hisaya FujiwaraDepartment of Obstetrics and Gynecology, Japan Organization of Occupational Health and Safety, Chugoku Rosai Hospital, Hiroshima, Japan.
Eiji HirataDepartment of Obstetrics and Gynecology, Hiroshima University, Hiroshima, Japan.
Yoshiki KudoDepartment of Obstetrics and Gynecology, Hiroshima University, Hiroshima, Japan.
Koji ArihiroDepartment of Anatomical Pathology, Hiroshima University Hospital, Hiroshima, Japan.
Norio MiharuDepartment of Obstetrics and Gynecology, Chuden Hospital, Hiroshima, Japan.
Tomio NakagawaDepartment of Radiation Oncology, National Hospital Organization Fukuyama Medical Center, Hiroshima, Japan.
Ippei TakahashiDepartment of Radiation Oncology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.
Yuki TakeuchiDepartment of Radiation Oncology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.
Nobuki ImanoDepartment of Radiation Oncology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.
Ikuno NishibuchiDepartment of Radiation Oncology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.
Takeo NakashimaSection of Radiation Therapy, Department of Clinical Support, Hiroshima University Hospital, Hiroshima, Japan.
Daisuke KawaharaSection of Radiation Therapy, Department of Clinical Support, Hiroshima University Hospital, Hiroshima, Japan.
Yoshimi OhnoSection of Radiation Therapy, Department of Clinical Support, Hiroshima University Hospital, Hiroshima, Japan.
Yasushi NagataDepartment of Radiation Oncology, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.
Hiroshima University · JPHiroshima University Hospital · JPChubu Electric Power (Japan) · JPFukuyama Cardiovascular Hospital · JPJapan Organization of Occupational Health and Safety · JPNational Hospital Organization · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In November 2011, a 61-year-old woman was diagnosed with squamous cell carcinoma (SCC) of the cervix in a uterus didelphys with vaginal septum. The patient was diagnosed with Fédération Internationale de Gynécologie et d'Obstétrique (FIGO) stage IIB because of infiltration to the left parametrium without infiltration to the pelvic wall. The patient was treated with external-beam radiotherapy (EBRT) and brachytherapy (BT), using concomitant chemotherapy with cisplatin. A total of 50 Gy were delivered (2 Gy/fraction/day) to the pelvis, with a central shield after 40 Gy. The patient was treated four times with BT (6 Gy × 4 fractions), with tandem and ovoid applicators inserted once to the left side; tandem to the left side and ovoid bilaterally were inserted twice; and tandem to the right side and ovoid bilaterally were inserted once. Six years and 8 months after the start of treatment, the patient had had no relapse or severe late adverse effects. For accurate diagnosis and optimal treatment of the uterus didelphys, careful interview and pelvic examination at initial diagnosis of a patient are very important.

Indexed as

brachytherapycervical cancerconcurrent chemoradiotherapyuterus didelphysvaginal septum

Identifiers

PMID31139228
PMCPMC6536144
OpenAlexW2938200085

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.